Pharmaceutical Competitive Intelligence

Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Conferences 2021

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

Master the marketplace

To succeed in the pharmaceutical marketplace, it’s vital to stay up to date with developments that can affect your business. Our competitive and market intelligence can give you all the credible, detailed information you need in one place.

What we offer

You can quickly access referenced information across global key industry developments in the pharmaceutical and medical technology markets with our easy-to-use solutions and expert analysts.

Build detailed competitive and market landscape analyses quickly, with access to global information on:

Drug and device development
Patient populations
Clinical trials
Drug and device patents
Market moving events
Patient-based sales forecasts

How it helps

We help you more accurately:

Prioritize pharmaceutical R&D spend by finding gaps and unmet needs through the analysis of competitors’ targets and R&D priorities
Understand disease epidemiology and disease sub-populations targeted in clinical development
Anticipate market changes through patent expiration tracking
Earmark who is entering or exiting your market via licensing or acquisition, as well as who is securing or providing funding
Project revenue for your pipeline and marketed drugs

Relevant products

Discover the power of Pharma360

Datamonitor Healthcare: data analysis and insight

Datamonitor Healthcare's expert coverage of key diseases, companies, drugs and market trends makes it the go-to product for pharmaceutical and biotechnology companies to support the development and validation of their strategic plans and commercial decisions.

Key benefits:

Prioritize market opportunities
Identify unmet needs
Make informed decisions

Biomedtracker: see the drug development process through analysts’ eyes

Real-time tracking and analysis of the drug development pipeline

Key benefits:

Market Events & Catalysts
Likelihood of Approval
Deals Coverage

View all content

Trialtrove: gold standard clinical trials intelligence

Introduction to the China Clinical Trials Landscape with Andy Benson

15 Oct 2021

Deep dive into China’s clinical landscape to learn more about the startling growth in clinical research in our whitepaper from Dr Annie Siu, PhD, MBA, APAC - Content Director, Informa Pharma Intelligence and Andrew Benson, MSc - Senior Director, Trialtrove.

Topic Business Strategies Clinical Trials

View white paper
Scrip

IPO Update: Average Return Turns Negative For Newly Public Biopharma Firms

By Mandy Jackson 05 Oct 2021

With 88 initial public offerings in the US through the end of the third quarter of 2021, the biopharma industry is two IPOs ahead of the full-year 2020 total, but with an average return of -4% momentum may slow.

View article
Scrip

Quick Listen: Scrip’s Five Must-Know Things

By Ian Haydock 04 Oct 2021

In this week's podcast edition of Five Must-Know Things: the prospects for Merck’s Acceleron acquisition; the pandemic and biotech capital in-flow; an interview with Menarini’s CEO; upcoming endocrine and metabolic product disorders; and an interview with Novartis Pharma’s president.

View article
Scrip

Merck’s Oral Antiviral Data In COVID-19 May Change Pandemic Outlook

By Joseph Haas 01 Oct 2021

Merck/Ridgeback’s ribonucleoside analog shows nearly 50% reduction of risk for hospitalization or death in Phase III study. Firms will seek EUA in US; a contract is in place for 1.7 million courses of therapy.

View article
Scrip

Sanofi’s Uses Latecomer COVID Data To Highlight Bigger mRNA Strategy

28 Sep 2021

The French drug maker isn’t moving its mRNA COVID-19 vaccine into Phase III, instead focusing on a GSK-partnered protein SARS-CoV-2 vaccine and applying mRNA technology elsewhere.

View article
Scrip

Ex-Amgen CIO McKenzie: 'We All Have To Think Like Software Companies'

By Anju Ghangurde 27 Sep 2021

Amgen’s former chief information officer Diana McKenzie highlights the inroads made by technology firms in healthcare and how life science companies can adapt from them while leveraging core capabilities at scale.

View article
Scrip

Quick Listen: Scrip’s Five Must-Know Things

By Ian Haydock 26 Sep 2021

In this week's podcast edition of Five Must-Know Things: an interview with the president of Novartis Pharma; Biogen highlights its pipeline; standout comparative data for Enhertu in breast cancer; Sanofi/Regeneron nip at Keytruda’s heels in first-line lung cancer; and a look at the market prospects for wet AMD.

View article
Biomedtracker, Datamonitor Healthcare

Key Potential Drug Launches in 2022

23 Sep 2021

Released July 22, 2021. Contains information like likelihood of approval (LOA) ratings and upcoming catalysts that are current as of April 2021.

Single report
Biomedtracker, Datamonitor Healthcare

2020 Deal-Making Roundup

21 Sep 2021

Against a backdrop of unprecedented disruption, the biopharma and medtech industries reached incredible heights for deal-making activity during 2020.

Topic Drug Review Coronavirus

View white paper
Scrip

Scrip Asia 100

20 Sep 2021

The highly anticipated Scrip Asia 100 is back, and there are a limited number of opportunities for you to be a part of it. Don’t miss your chance to connect to APAC market leaders with a high-profile sponsorship of this essential annual financial performance ranking of pharma companies headquartered in the APAC region.

Topic Business Strategies

Single report
Scrip

Quick Listen: Scrip’s Five Must-Know Things

By Ian Haydock 06 Sep 2021

In this week's podcast edition of Five Must-Know Things: new US warnings for JAK inhibitors; strong new heart failure results for Jardiance; good head-to-head results for Pfizer in atopic dermatitis; US payers and drug exclusion lists; and a look ahead at key expected hematology launches.

View article
Biomedtracker, Meddevicetracker

Q3 2021 Outlook Report

27 Aug 2021

What major drug catalysts and events can you expect to see in the months ahead? Download your free extract from the Q3 2021 Outlook Report and infographic to find out. Shape your strategy with your inside look at what’s to come.

Topic Drug Review

Single report
Scrip

Chinese Biotechs Join COVID-19 Treatment Race With Repurposed Cancer Drugs

By Dexter Yan 18 Aug 2021

Chinese bioventures leap into the COVID cure fray as two little-known companies kick off clinical studies of androgen receptor antagonists in Brazil and the US.

View article
Scrip

Quick Listen: Scrip’s Five Must-Know Things

By Ian Haydock 16 Aug 2021

In this week's podcast edition of Five Must-Know Things: a history of Alzheimer’s drug development; BioNTech looks beyond COVID-19 vaccines; gene therapy setbacks for bluebird; new promise for Roche’s Polivy in B-cell lymphoma; and rising US momentum for US drug price negotiations.

View article
Datamonitor Healthcare, Biomedtracker, Scrip

2021 Post-ASCO Insights and Analysis

11 Aug 2021

The American Society of Clinical Oncology (ASCO) hosted its annual meeting from June 4-8 2021 and our team has the exclusive insights and analysis you can access today.

Topic Cancer

Single report

Latest headlines

Scrip

15 Oct 2021

AstraZeneca's Imfinzi/Tremelimumab Combo Conquers HIMALAYA

Link
Scrip

15 Oct 2021

Can Sarepta Beat Pfizer To A Duchenne Gene Therapy Breakthrough?

Link
Scrip

15 Oct 2021

EuBiologics On COVID-19 Vaccine And Fulfilling Public Health Mission

Link
Scrip

15 Oct 2021

The Next Big Thing In Gene Therapy Might Not Be Gene Therapy

Link
Scrip

15 Oct 2021

Gilead Sees Room For Trodelvy In European Markets

Link
Scrip

15 Oct 2021

Pfizer Testing Warranty Offer With Xalkori, May Expand It To ‘Multiple’ Products

Link
Scrip

15 Oct 2021

BeiGene/BMS Parting Abraxane Ways As China Supply Woes Continue

Link
Scrip

15 Oct 2021

Pipeline Watch: Phase III Readouts in Fabry's Disease And COVID-19

Link
Scrip

14 Oct 2021

Coronavirus Update: Brii Files US EUA For Antibody Combo

Link
Scrip

14 Oct 2021

US Vs. EU: Is Cell And Gene Therapy Reimbursement Easier Stateside?

Link
Scrip

14 Oct 2021

Q3 Headwinds For Pharma Could Dampen A Continued Rally

Link
Scrip

14 Oct 2021

Keytruda Cements Cervical Cancer Leadership With First-Line Nod

Link
Scrip

14 Oct 2021

Asia Deal Watch: Hansoh Teams Up With OliX On SIRNA Therapies

Link
Scrip

14 Oct 2021

Exelixis Moves Into RNA-Modifying Cancer Therapy With Storm Pact

Link
Scrip

14 Oct 2021

Catch-22: Biotech Boom Brings Clinical Services, Regulatory Crunch In China

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

Client Services

US Toll-Free : +1 888 670 8900
US Toll : +1 212-600-3520
UK & Europe : +44 (0) 208 052 0700

Contact Customer Services

Pharma Report Store

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now:

Shop now

Get ahead with in-depth pharmaceutical competitive intelligence

​Master the marketplace

Relevant products

Below are the Product List

Discover the power of Pharma360

Datamonitor Healthcare: data analysis and insight

Biomedtracker: see the drug development process through analysts’ eyes

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

Client Services

Pharma Report Store

Master the marketplace